Clinical Trials

Showing 201 - 220 of 488 trials
Titlesort icon Investigator Disease(s)
A Phase II Study of Tretinoin plus Arsenic Trioxide in Newly Diagnosed Acute Promyelocytic Leukemia Followed by Risk-Adapted Therapy
[Protocol 11-040]
Park, Jae
  • Leukemia
    • Acute Myelogenous Leukemia
A Phase II Study of Tremelimumab versus Placebo for Previously Treated Inoperable Mesothelioma
[Protocol 13-092]
Krug, Lee
  • Mesothelioma
A Phase II Study of Treatment-Free Remission in Chronic-Phase Chronic Myelogenous Leukemia Patients Who Achieve and Sustain a Complete Molecular Response After Switching to Nilotinib
[Protocol 13-152]
Berman, Ellin
  • Leukemia
    • Chronic Myelocytic Leukemia
A Phase II Study of Transoral Surgical Removal of HPV-Positive Locally Advanced Oropharynx Cancer Followed by Risk-Stratified Therapy
Relapsed/Refractory
[Protocol 14-035]
Morris, Luc
  • Head & Neck Cancer
A Phase II Study of Trametinib with and without GSK2141795 in Patients with Advanced Uveal Melanoma
[Protocol 13-144]
Carvajal, Richard
  • Melanoma
    • Melanoma of the Eye
A Phase II Study of the MatriStem Surgical Matrix to Reinforce the Esophagus in Patients Having Surgery for Gastric and Esophageal Cancer
Newly Diagnosed & Relapsed/Refractory
[Protocol 13-178]
Strong, Vivian
  • Upper Gastrointestinal
    • Esophageal Cancer
    • Gastric Cancer
A Phase II Study of Temozolomide plus Irinotecan with or without Bevacizumab in Children with Recurrent or Refractory Medulloblastoma or PNET
[Protocol 11-089]
De Braganca, Kevin
  • Pediatric Brain Tumors
    • Brain Cancer
A Phase II Study of Temozolomide Alone or with ABT-888 (Veliparib) in Patients with Relapsed or Refractory Small Cell Lung Cancer
[Protocol 12-021]
Pietanza, M. Catherine
  • Lung Cancer
  • Lung Cancer, Small Cell
    • Other
A Phase II Study of Temozolomide Alone and with Capecitabine in Patients with Advanced Pancreatic Neuroendocrine Tumors
[Protocol 13-194]
Reidy-Lagunes, Diane
  • Upper Gastrointestinal
    • Neuroendocrine
    • Pancreatic Cancer
A Phase II Study of Sorafenib plus Doxorubicin in Patients with Liver Cancer that Continued Growing with Sorafenib Therapy
[Protocol 12-259]
Abou-Alfa, Ghassan
  • Hepatobiliary
    • Liver Cancer
A Phase II Study of SNX-5422 in Patients with Select Advanced HER2 Cancers
[Protocol 13-112]
Voss, Martin
  • Bladder Cancer
  • Breast Cancer
  • Kidney Cancer
  • Lung Cancer, Non-Small Cell
  • Upper Gastrointestinal
    • Esophageal Cancer
    • Gastric Cancer
A Phase II Study of Secondary Cytoreduction with and without HIPEC plus Postoperative Chemotherapy for Women with Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Relapsed/Refractory
[Protocol 12-275]
Chi, Dennis
  • Ovarian Cancer
A Phase II Study of Rucaparib in Patients Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Relapsed/Refractory
[Protocol 13-255]
Bell-McGuinn, Katherine
  • Ovarian Cancer
A Phase II Study of Romidepsin after Autologous Stem Cell Transplantation in Patients with T-Cell Non-Hodgkin Lymphoma
[Protocol 13-020]
Goldberg, Jenna
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase II Study of Response-Based Radiation Therapy for Patients with Localized Germ Cell Tumors of the Central Nervous System
[Protocol 12-243]
Dunkel, Ira
  • Germ Cell Tumors
  • Pediatric Brain Tumors
    • CNS Cancer
A Phase II Study of Regorafenib in Patients with Recurrent or Metastatic Adenoid Cystic Carcinoma
[Protocol 13-244]
Ho, Alan
  • Head & Neck Cancer
A Phase II Study of Radioactive Iodine with and without Selumetinib in Patients with High-Risk Thyroid Cancer After Thyroidectomy
[Protocol 13-133]
Ho, Alan
  • Thyroid Cancer
A Phase II Study of RAD001 (Everolimus) and Pasireotide (SOM230)) in Patients with Advanced Uveal Melanoma
[Protocol 10-123]
Carvajal, Richard
  • Melanoma
    • Melanoma of the Eye
A Phase II Study of Pomalidomide plus Autologous Stem Cell Transplantation versus Pomalidomide/Dexamethasone in Patients with Multiple Myeloma
Relapsed/Refractory
[Protocol 12-138]
Giralt, Sergio
  • Hematology
    • Multiple Myeloma
A Phase II Study of Pimasertib with SAR245409 or a Placebo in Women with Previously Treated Inoperable Low-Grade Ovarian Cancer
[Protocol 13-173]
Grisham, Rachel
  • Ovarian Cancer